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ABSTRACT 
 
Objective: This study aimed to explore the effects of acute phenylalanine-tyrosine depletion 
(APTD) and acute tryptophan depletion (ATD) on bimodal divided attention. A balanced 
amino acid mixture (BAL) served as control condition.  
Methods: 54 healthy adults (age: M = 23.8 years) were randomly assigned to APTD, ATD or 
BAL in a double-blind, between-subject approach. Divided attention was assessed after 4 
hours. Blood samples were taken before and 6 hours after challenge intake. 
Results: Amino acid concentrations following challenge intake significantly decreased (all p 
≤ .01). There was a significant difference in the mean reaction time (RT) towards auditory 
stimuli, but not towards visual stimuli between the groups. Post-hoc comparison of mean 
RT’s (auditory stimuli) showed a significant difference between ATD (RT = 604.0 ms, SD = 
56.9 ms) and APTD (RT = 556.4 ms, SD = 54.2 ms; p = .037), but no RT-difference between 
ATD and BAL or APTD and BAL (RT = 573.6 ms, SD = 45.7 ms).  
Conclusion: The results indicate a possible dissociation between the effects of a diminished 
brain 5-HT and DA synthesis on the performance in a bimodal divided attention task. The 
difference was exclusively observed within the RT towards auditory signals.  
 
Key words: Acute tryptophan depletion, phenylalanine tyrosine depletion, serotonin, 
dopamine, attention, healthy volunteers 
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INTRODUCTION 
 
The ability to allocate attention simultaneously to concurrent stimuli is essential for many 
daily life activities. Aberrant performance in this particular attentional domain is considered 
to be a pathognomonic hallmark in patients with, but not limited to, schizophrenia (Allen 
1982; Ahlers et al. 2014; Shen et al. 2014), major depressive disorder (Thomas et al. 1998; 
Majer et al. 2004) and attention deficit hyperactivity disorder (Macleod and Prior 1996). 
Accordingly, a thorough understanding of the biochemical processes involved in divided 
attention is mandatory. The biogenic amines serotonin (5-HT) and dopamine (DA) are known 
to play a crucial role in the regulation of mood and cognitive processes (Robbins 2005; Ruhé 
et al. 2007), and dysfunction of these neurotransmitter systems is believed to be critical in the 
pathogenesis of the mentioned psychiatric disorders.  
 
Experimental manipulation of brain DA and 5-HT systems allows to examine the contribution 
of these neurotransmitter systems to the neurochemical processes underlying attention.. 
Therefore, dietary neurotransmitter precursor depletion techniques such as acute tryptophan 
depletion (ATD, which leads to a decreased central nervous synthesis rate of 5-HT) or acute 
phenylalanine tyrosine depletion (APTD, which decreases DA synthesis in the brain) have 
become favorable tools in neuropsychological research (Booij et al. 2003; Young 2013; 
Biskup et al. 2015).  
 
The two neurodietary procedures ATD and APTD build on the fact that the amino acid (AA) 
tryptophan (TRP) is the physiological precursor of 5-HT, and that AAs phenylalanine (PHE) 
and tyrosine (TYR) serve as essential substrates for central nervous system DA synthesis 
(Moja et al. 1988; Moja et al. 1996; Sheehan et al. 1996; Young 2013). Given that both 5-HT 
and DA cannot overcome the blood brain barrier, the formation of these monoamines depends 
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on the availability of their respective physiological precursors, which belong to the group of 
large neutral amino acids (LNAAs), in the central nervous system. All LNAAs compete for 
the same transporter system at the blood brain barrier (Oldendorf and Szabo 1976), whereas 
the amount of TRP or PHE entering the brain by passive diffusion is negligible under 
physiological conditions (Momma et al. 1987; Smith et al. 1987). 
 
Precursor influx is determined by the ratio of the respective AAs to the competing LNAAs 
(see for example Dingerkus et al. 2012). Enzymes related to the rate-determining step of 
central nervous 5-HT- and DA-synthesis are not saturated under physiological conditions 
(Carlsson and Lindqvist 1978; Young and Gauthier 1981), and a reduction in this particular 
ratio decreases central nervous 5-HT and/or DA synthesis. Depletion of 5-HT and DA in the 
central nervous system therefore can occur via diminished precursor availability due to a 
decreased dietary AA intake and dietary administration of competing LNAAs, whereby the 
latter also stimulates protein biosynthesis, so that preexisting precursor AAs are withdrawn 
from circulation (Moja et al. 1991). The significance of the ensuing effects on central 
monoamine turnover has been documented both in animal and human studies (Booij et al. 
2003; Ruhé et al. 2007; Mendelsohn et al. 2009; Biskup CS et al. 2012; Young 2013; Sanchez 
et al. 2014). As demonstrated for the ATD protocol a signiﬁcant reduction of the TRP inﬂux 
occurs 90 minutes after ATD intake and reaches a nadir at 240 minutes, which is followed by 
a slow recuperation, whereas the TRP influx is still decreased at about 50% at 360 minutes 
after intake (Linden et al. 2016), Dingerkus et al. 2012).  
 
Studies in animals and humans provide broad evidence for a serotonergic influence on 
dopaminergic neurotransmission. Early findings suggested a general opponency between both 
neurotransmitters systems, however, recent studies have indicated that also facilitating effects 
may occur (Daw et al. 2002; Cools et al. 2011). Hence, a more complex model including 
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collaborative and opponent effects has been proposed (Boureau and Dayan 2011). The 
complex interaction of both systems is particularly apparent when the role of the prefrontal 
cortex (PFC) is examined. Playing a major role in attentional performance, the PFC is under 
the complex control of ascending monoaminergic projections, which in turn are under top-
down control by the PFC (Robbins 2005). Functional and structural brain research identified 
the PFC as the fulcrum of cortico-striatal loops (Alexander et al. 1986; Robbins 2005). These 
frontostriatal systems are involved in a number of psychological processes intimately linked 
to executive functioning, like decision-making, selection and perception of novel information 
or behavioral control (Boulougouris and Tsaltas 2008).  
 
There is a plenty of evidence that these circuits, which modulate executive functioning, are 
under serotonergic as well as dopaminergic influence, and that disturbances thereof are related 
to psychiatric disorders (Robbins 2005; Boulougouris and Tsaltas 2008). Due to its crucial 
importance to executive and attentional processing, Shallice and Norman considered the PFC 
as the neural substrate of the ‘supervisory attentional system’ (SAS) in their model of 
executive functioning of attentional control (Shallice 1982, 2004). The concept of a SAS was 
also included in the conceptual framework of attentional functioning provided by Zomeren 
and Brouwer (1994). The model by Zomeren and Brouwer regarding attention distinguishes 
between the selectivity and intensity of attention and proposed SAS as a modulating and 
controlling mechanism. Furthermore, the attention aspect of intensity was subdivided into 
“alertness” and “sustained attention”, whereas attention selectivity was subdivided into 
“focused attention” and “divided attention”. 
 
To date, a limited number of experiments provided insight into the neural substrates of cross-
modal divided attention. Experiments employing functional neuroimaging have highlighted 
the contribution of the dorsolateral PFC, as well as increased activation in regions such as the 
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cingulate cortex or decreased activation in sensory cortices (Loose et al. 2003; Johnson and 
Zatorre 2005, 2006; Vohn et al. 2007; Chiang et al. 2013). However, less is known about the 
neurochemical underpinning of the concurrent allocation of attentional resources towards 
bimodal stimuli. The impact of ATD and APTD on attention has been investigated in several 
studies, although the majority of studies applied ATD instead of APTD, and only a few 
studies applied both (ATD and APTD). A review by (Mendelsohn et al. 2009) summarized 
the effects of ATD on memory, attention and executive functions. The authors concluded that 
there were mixed results, where sustained attention, divided attention or attentional set-
shifting were unaffected by ATD, while some studies reported improved performance 
regarding focused attention and an improved interference performance in a stroop task 
(Mendelsohn et al. 2009).  
 
The published results on the effects of APTD on attention-related processes are also 
inconsistent. Scholes and colleagues reported improved attentional control in a stroop task 
after the administration of both ATD and APTD (Scholes et al. 2007), while Vrshek-
Schallhorn (2006) et al observed impairments in a Go/No-Go paradigm after APTD 
administration. In contrast, Lythe and co-workers found no effect of APTD on Go/No-Go task 
performance as well as on set-shifting performance (2005). The latter findings are in line with 
the results provided by McLean et al. (2004) and Grevet et al. (2002). It is important to note 
that in the studies by Lythe, McLean and Grevet, the impact of APTD did not significantly 
differ from the impact of placebo on all aspects of attention investigated. To date, no studies 
exist that investigated the effects of APTD on performance in tests relating to divided 
attention in humans.  
 
In this explorative study we used an APTD mixture dosed in accordance with body weight to 
reduce side effects, as this approach was already successfully employed by recent research in 
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children and adolescents using ATD (Stadler et al. 2007; Kötting et al. 2013). Cross-modal 
divided attention performance as well as working memory performance, mood ratings and 
relevant plasma levels of different AAs were compared with an established body weight 
adapted ATD protocol and a balanced amino acid mixture (BAL) serving as a control 
condition. To the best of our knowledge, this is the first study to investigate the effects of a 
diminished central nervous synthesis of DA and 5-HT on bimodal divided attention and to 
provide data to calculate sample sizes for future research. A larger neuropsychological test 
battery was employed to assess, whether changes in bimodal attention were independent from 
other cognitive domains (e.g. mood), which are assumed to be related to dysfunction in these 
particular transmitter systems.  
 
 
 8 
MATERIALS AND METHODS 
 
Subjects and study design 
The study design was a randomized double-blind between-subject design, with the 
administration of ATD, APTD or BAL to healthy volunteers. Inclusion criteria were good 
physical health and the absence of any psychiatric or somatic disorder. Healthy adult 
volunteers of both genders were recruited and screened for psychiatric disorders by using a 
structured interview (SKID-light) (Demal 1999.). Key exclusion criteria were current or past 
history of any psychiatric or neurological disorder as defined in the ICD-10, primary somatic 
or any other chronic diseases, substance abuse, pregnancy in female subjects and an IQ lower 
than 85. The study was assessed and approved by the local Ethics Committee, and was carried 
out in accordance with the Declaration of Helsinki. Written and oral informed consent was 
obtained from all participants prior to participation, and after the study subjects were 
financially compensated for their participation. In order to provide consistent environmental 
conditions, the study was carried out at the clinical research ward of the Jülich Research 
Centre. Participants were instructed to not consume alcohol the night before and on the day of 
the study, and to ensure sufficient sleep the night before the day of participation. All subjects 
were required to confirm that these instructions were followed prior to participation. After a 
12-hour protein-fast, participants received a standardized low protein breakfast containing no 
TRP in the morning of the day of the investigation. Upon arrival at the study site, all subjects 
undertook a drug and pregnancy test (female subjects) before being randomly assigned to 
receive one of the three challenge conditions (ATD, APTD, BAL) in a double-blind, between-
subject approach. The neuropsychological assessment ended with an fMRI-task that was 
administered 300 minutes post intake (data from this experiment are the subject of a different 
publication). Serum and plasma samples were taken at two time points; before challenge 
intake (T0), and after the last task of a neuropsychological testing battery (T6h).  
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Depletion procedure 
All AA compositions that were used in this study were based on the Moja-De protocol for 
acute tryptophan depletion (Zepf 2008). The AAs for the TRP balanced control condition 
(BAL) were dosed in accordance with the body-weight of the subjects and contained the 
following quantities (per 10 kg body weight): L-phenylalanine (1.32 g), L-leucine (1.32 g), L-
isoleucine (0.84 g), L-methionine (0.5 g), L-valine (0.69 g), L-threonine (0.6 g), L-lysine 
(0.96 g, as 1,2g L-lysine-HCL) and L-tryptophan (0,7g). The ATD (depletion of brain 5-HT 
synthesis) and APTD (depletion of brain DA synthesis) AA mixtures were deficient of the 
precursor TRP (ATD), and the precursors PHE and TRY (APTD) for the respective challenge 
procedures. In line with the dosage of the AAs of the BAL control condition, the relevant 
AAs of the ATD and APTD procedure (i.e., excluding the aforementioned precursors) used 
the same AA quantities as per 10kg body weight. The mixtures were administered within an 
aqueous suspension as a beverage. Subjects were instructed to quickly consume the beverage.  
 
Neuropsychological assessment  
The computer-based Test of Attentional Performance Version 2.0 (TAP) was used to assess 
performance in divided attention (DV) and working memory (WM) four hours after challenge 
intake. Subjects were instructed to react to crucial stimuli as quickly as possible by pressing a 
button. Reaction time, omission and commission errors were registered. The working memory 
task used a 2-digit backward paradigm. Numbers from 1–9 were presented on screen in a 
putative arbitrary order. Subjects were required to respond when the presented number 
equaled the number that was presented two positions prior. The divided attention task 
required subjects to simultaneously react to a visual and auditory stimulus. Subjects were 
visually presented a 4x4 dot matrix that consisted of a varying number of crosses whilst being 
played a series of high and low pitched tones. Subjects were required to respond when four 
 10 
adjacent crosses formed a square and when a tone of the same pitch was presented 
consecutively.  
 
Mood assessment 
Throughout the study day, mood was assessed hourly using the ASTS, a brief German 
adaption of the Profile of Mood Scale (POMS). This self-rated questionnaire comprises 19 
adjectives scored on a Lickert-scale ranging from 1 (not strong) to 7 (very strong). The ASTS 
measured subjective mood states on the five subscales “sadness,” “hopelessness,” “tiredness,” 
“anger” and “positive mood”. Negative emotion scores were calculated by summing up the 
first three subscales and the reversed values of the positive items.  
 
Laboratory assessment 
Venous blood samples were collected before and 6 hours after challenge intake. The tubes 
contained either Potassium-ETDA as anticoagulant to obtain plasma or silicate beads as 
clotting activator to obtain serum samples. The blood samples were stored at ambient 
temperature for 30 min, and then centrifuged at 2.500g for 10 min. The supernatant was 
stored at -80°C until laboratory analysis were carried out. TRP, PHE, TYR concentrations 
were measured using an immunosorbent assay (ELISA) kit, and concentrations of the 
competing BCAAs were analyzed using a commercially available enzyme BCAA test kit 
(Immundiagnostik AG, Bensheim, Germany, both).  
 
Data analysis 
Tukey’s outlier test was applied, and normality of data was assessed using the Shapiro-Wilk 
Test. Due to the non-normal distribution of the data, which could not be corrected by 
conventional data transformation, plasma samples were analyzed using a non-parametric 
approach. Wilcoxon signed-rank tests were performed to investigate changes relative to 
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baseline within the treatment groups. Kruskal-Wallis-Tests were used to evaluate differences 
between treatment groups. Post-hoc comparisons were carried out by Mann-Whitney Tests, 
the level of statistical significance was manually adjusted in accordance with Bonferroni (𝛼 =0.017). One-way analyses of variance (ANOVA) were used to compare the results from the 
data derived by the TAP; Mood data were analyzed using a split-plot ANOVA. The level of 
statistical significance was set at p = < 0.05. Because of the explorative nature of the study, 
the results were not subjected to alpha-adjustment. All statistical analyses were carried out 
using SPSS® for Microsoft Windows®. As this study was conducted as a pilot study providing 
data to calculate sample sizes for future research, a post-hoc power analysis was carried out 
using G*power®.  
 
RESULTS 
 
In total, N = 53 subjects participated in the study, however after screening, the data of 4 
subjects were excluded for various reasons, i.e. outliers in terms of unusually high error rates 
during the administered attention task, one subject in the APTD group was withdrawn from 
the study because of nausea approx. four hours after challenge-intake. This yielded a final 
sample of N = 49 subjects, the data of which were used for the final statistical analysis. The 
characteristics of the subjects in the final analyses are given in Table. 1. 
 
(please insert Tab. 1 about here) 
 
Blood sample analysis 
The mean concentrations of all assessed AAs as well as the calculated AA ratios at each point 
for each treatment group are shown in Tab. 2 and Fig. 1. At baseline (T0), no significant 
differences in plasma levels were observed between the three groups with respect to the 
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relevant precursors (TRPT0 χ² (2, N =49) =1.50, p =.47; PHE T0 χ² (2, N =49) = .59, p =.75; 
TYR T0 χ² (2, N =49) =.59, p = .74; BCCA T0 χ² (2, N =49) = .37, p = .83). Changes in plasma 
AA concentrations after challenge intake were in the expected direction (decrease), and these 
changes were found to be significant. A Kruskal-Wallis test followed by a Mann-Whitney-U-
Test indicated statistically significant differences in plasma levels between challenge 
treatment groups at time point T(6h) (TRPT6h χ² (2, N =49) = 32.08; PHE T6h χ² (2, N = 49) = 
32.73; TYR T6h χ² (2, N = 49) = 32.63, p <0.001, all); TRP T6h: BAL vs. ATD z = -4.82, p < .001; 
ATD vs. APTD z = -4,90 p < .001; PHE T6h: BAL vs. APTD z = -4.90, p < .001 ATD vs. APTD z = -4.90, p < 
.001; TYR T6h: BAL vs. APTD z = -4.86, p < .001; ATD vs. APTD z = -4.90, p < .001). Changes from 
baseline in plasma levels of TRP or TYR and PHE as well as the respective AA ratios were 
significant within treatment groups as determined by Wilcoxon signed-rank tests (ATD: 
TRPT0h vs. TRPT6h z = -3.64, p < .001; TRP/LNAAT0h vs. TRP/LNAAT6h  z = -3.52, p < .001|| 
APTD: PHET0h vs. PHET6h z = -3.62, p < .001; PHE/LNAAT0h vs. PHE/LNAAT6h  z = -3.62, p 
< .001; TYRT0h vs. TYRT6h z = -3.62, p < .001 ; TYR/LNAAT0h vs. TYR/LNAAT6h  z = -3.62, 
p < .001).  
 
(please insert Tab. 2 and Fig. 1 about here) 
 
Mood Assessment 
No significant changes from baseline in negative emotion scores or scores for tiredness were 
detected at the time of the neuropsychological assessment. There were no statistically 
significant time*group interactions (F (2, 46) = .44, p =.65, η2 = .02) or main effects of time (F 
(1, 46) = .22, p =.65, η2 = .005). (Table 3) 
 
(Fig. 2, Fig. 3, Tab. 3 and Tab. 4) 
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Neuropsychological assessment 
No significant group differences in reaction times (F (2, 46) = 0.42, p = 0.66), correct responses 
(F (2, 46) = 0.08, p = 0.92) or omission error rates (F (2, 46) = 0.08, p = 0.92) were found in the 
working memory task (Tab. 4). A one-way ANOVA indicated a significant difference in the 
mean reaction time (RT) towards auditory stimuli (F (2, 46) = 3.46, p = 0.04) but not towards 
visual stimuli between the challenge groups in the divided attention task. A Bonferroni post-
hoc comparison of the mean RT to auditory stimuli showed a significant difference between 
ATD (RT = 604.0 ms, SD = 56.9 ms) and APTD (RT = 556.4 ms, SD = 54.2 ms; p = .037) 
administration, but no difference in RT between ATD and BAL or APTD and BAL 
administration (RT = 573.6 ms, SD = 45.7 ms; Fig 1a/b). The one-way ANOVA of the 
reaction times toward auditory stimuli revealed a moderate to large effect size of 0.131 
(partial eta squared). Based on this effect size a post-hoc power analysis revealed an overall 
statistical power (1-β) of 0.66.  
 
DISCUSSION  
 
To the best of our knowledge, this pilot study is the first that provides data regarding the 
effects of ATD and APTD on bimodal attentional performance in healthy adult participants. 
The results, albeit in a small sample size, indicate a possible dissociation between the effects 
of a short-term diminished central nervous 5-HT and DA synthesis on the performance in a 
bimodal divided attention task in healthy subjects. In particular, the difference was 
exclusively observed for reaction times towards auditory stimuli, whereas mean reaction time 
towards visual cues remained unaffected.  
 
No significant group differences towards the balanced condition were observed, which may 
be due to the small sample size. Previous studies have not found effects of ATD on measures 
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of divided attention, but the paradigms used in prior studies were not comparable to the 
present approach (Schmitt et al. 2000; Sobczak et al. 2002). However, the mean reaction time 
towards auditory stimuli in the balanced conditions was intermediate between the reaction 
times following ATD and APTD. This effect was irrespective of mood changes or 
wakefulness. The lack of fluctuation in mood observed in the present experiment is in line 
with previous findings indicating no alteration in mood following dietary monoamine 
depletion methods in healthy volunteers who do not have a history of an affective disorder 
(Ruhé et al. 2007). Moreover, no effects were observed on working memory, and - as has also 
been reported previously - both on phasic alertness and in a simple reaction task (Hildebrand 
et al. 2015). The former is of particular interest, regarding the proposed contribution of 
working memory to divided attention (Santangelo and Macaluso 2013).  
 
In summary, it seems likely that the observed difference between the reaction times toward 
auditory stimuli is neither promoted by impairments in vigilance or motor response nor 
confounded by effects on working memory. Therefore, decreasing the central synthesis of 
dopamine and serotonin seems to play a role in the attentional performance towards auditory 
stimuli in a dual task paradigm. No definite conclusion can be drawn whether this apparent 
opponent effect emerges from the same neurophysiological level. Therefore the possible 
contributions of 5-HT and DA are discussed separately. 
 
The administration of a TRP-free AA mixture resulted in a significant decrease in plasma 
levels of the particular AA and their calculated ratios. Decreases in total TRP levels were less 
distinct than in our previous findings and prior reports in literature (Mendelsohn et al. 2009). 
However, the change in the TRP-LNAA-ratio, a more valid estimator of the TRP-influx 
through the blood brain barrier, reached 65%, which is comparable with previous findings. 
This suggests that the depletion magnitude in our experiment was sufficient to diminish 
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central 5-HT synthesis, which is congruent with studies assessing depletion magnitude using 
nuclear imaging (Nishizawa et al. 1997), fenfluramine-prolactine-response (Coccaro et al. 
1998) or cerebrospinal fluid metabolites measures (Williams et al. 1999). These results were 
also corroborated by an experiment in mice applying the identical depletion protocol (Sanchez 
et al. 2014). In the experiment by (Sanchez et al. 2014), ATD resulted in a marked reduction 
of the 5-HT turnover in the frontal cortex. This is of particular interest, given the relevance of 
the PFC with regard to the allocation of attentional resources.  
 
To date, ATD has not been applied in experiments that utilized tasks of cross-modal divided 
attention. The neural substrates of cross-modal divided attention have been elucidated in a 
few functional imaging studies. Johnson et al. demonstrated that dividing attention between 
auditory and visual events resulted in an activation of the dorsolateral PFC (Johnson and 
Zatorre 2005, 2006). In a subsequent experiment, the authors showed that the ability to split 
attention deteriorated when there was a temporary disruption of dorsolateral PFC functioning 
(achieved through the use of transcranial magnetic stimulation) (Johnson et al. 2007). An 
fMRI study using the same attentional task revealed that splitting attention between visual and 
auditory stimuli resulted in an activation of the left PFC and the cingulate cortex as well as 
decreased activation in sensory brain areas (Loose et al. 2003). A study conducted by Vohn et 
al. observed activation in the right PFC, the right parietal cortex and the right claustrum under 
a cross modal divided attention paradigm (Vohn et al. 2007).  
 
Overall, enhanced activity of the DLPFC and the ACC is fundamental in cross-modal divided 
attention tasks. Thus, the observed longer RT in the ATD group compared to those in the 
APTD group could be driven by modulation in these specific brain areas. A depressant effect 
of ATD on these brain areas has been shown in several imaging studies (Biskup et al. 2015). 
But aside from a SPECT study (Talbot and Cooper 2006) showing an attenuated regional 
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cerebral blood flow in the left dACC following ATD, these effects were reserved to 
participants showing mood effects or were observed in the context of different stimuli. 
 
A further explanation as to why the difference was exclusive to auditory cues could be the 
prominent role of 5-HT within the auditory system. Serotonergic neurons innervate the 
auditory system from cochlea to cortex (Hurley and Hall 2011). It has been shown that ATD 
modulates pre-attentive auditory change detection and early phases of auditory processing 
(Ahveninen et al. 2002; Ahveninen et al. 2003). As demonstrated at the subcortical level, the 
serotonergic input depends on the behavioral state (Hall et al. 2010; Hurley and Hall 2011). 
Therefore, under the demanding condition of a dual task, the auditory system could be 
especially prone to alteration in the serotonergic system.  
 
The APTD resulted in a comparable depletion of the relevant AAs. The PHE-LNAA-ratio and 
the TYR-LNAA-ratio were decreased by 65% and 82%, respectively. The depletion 
magnitude is comparable to previous studies (Booij et al. 2003). Notably, following the BAL 
and ATD treatment, the tyrosine plasma levels increased. Given that tyrosine was lacking in 
all AA compositions used in this experiment, this may be explained by a partial conversion of 
phenylalanine into tyrosine. Nevertheless, the increase of tyrosine occurred to a considerably 
lower extent compared to the increase of the LNAAs. Consequently, the TYR/LNNA ratios 
slightly declined both in the BAL and ATD condition when compared to the APTD condition.  
 
At least at first sight, a faster reaction time under APTD relative to ATD may appear counter-
intuitive because dopaminergic stimulation is thought to improve attentional performance. 
Indeed, a large number of studies have provided evidence for this. However, optimal 
cognitive performance depends on an optimal level of DA. The relationship between optimal 
cognitive performance and levels of DA has been proposed to follow an “inverted u-shape”, 
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which is also dependent on the baseline behavioral state (Cools and D'Esposito 2011). 
Therefore, under specific conditions, a reduced dopaminergic tone may improve attentional 
performance as shown in experiment by Scholes et al (Scholes et al. 2007).  
 
The findings of the current study show that dietary depletion techniques cannot be discussed 
from a one-dimensional quantitative perspective. Whilst former depletion studies targeted 
localized lesions or specific DA antagonists, dietary approaches decrease dopaminergic tones 
in a general manner and, as shown in animal studies, preferentially in specific cerebral 
regions. For instance, noradrenergic neurons are considered to be “immune” to dietary 
manipulation (Sheehan BD et al. 1996; McTavish et al. 1999). Therefore, it is likely that 
different kinds of dopaminergic neurons show different vulnerabilities towards a precursor 
deficiency. Additionally, DA itself exhibits different affinities to distinct receptor subtypes 
(Missale et al. 1998). Consequently, a decreased synaptic DA level affects different DA 
receptors in a divergent manner. Therefore APTD does not only result in an irregular 
reduction of dopaminergic functioning, but also in an enhanced DA efflux in specific 
neurocircuits. Inhibition of dopaminergic signaling by DA antagonists increases frontal 
dopaminergic function as has been shown by several neuropharmacological studies 
(Hernandez and Hoebel 1989; Liegeois et al. 2002).  
 
An experiment using the same depletion technique in mice revealed a specific decrease in DA 
turnover in the striatum whereas the dopamine levels in the frontal cortex were not 
significantly affected (Sanchez et al. 2014). This is of particular interest, because a study in 
common marmosets showed that localized DA depletion of the striatum was associated with a 
greater focusing in a task requiring selective attention (Crofts et al. 2001). These results are in 
line with findings indicating that sulpirid enhances focusing in attentional tasks in humans 
(Mehta et al. 2004). Therefore, the relative variation in reaction times relative to ATD could 
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be associated with improved prefrontal attentional control caused by a predominantly striatal 
dopamine depletion. This hypothesis is supported by human PET studies and animal 
experiments, indicating a predominant effect of ATPD on striatal structures (Mehta et al. 
2005; Sanchez et al. 2014). Of note, APTD decreased striatal activity and increased activation 
in the PFC in an fMRI task related to reward processing (Frank et al. 2016). The 
improvements associated with APTD in task performance when compared to ATD may be 
caused by the modulation of cortico- striatal loops, whose functioning is crucial for attentional 
processes as mentioned introductorily. The modulation of the fronto-striato-circuitry by 
APTD has previously been studied by Scholes et al. in the context of reduced stroop 
interference under DA depletion (Scholes et al. 2007). 
 
The collateral effects of this depletion method should also be considered. The intended 
decrease in the precursor efflux of the targeted monoamine concomitantly modulates the ratio 
of the relative neurotransmitter’s precursors. Hence, ATD collaterally increases the 
availability of the DA precursors and APTD increases the availability of the 5-HT precursors. 
This is often considered as a limitation in depletion studies, although, the opponent effects 
that are attributable to DA and 5-HT functioning additionally underpin the hypothesis that the 
dissociation between the effects of a diminished central nervous 5-HT and DA synthesis are 
driven by an opponent DA-5HT interaction. Therefore it seems appropriate to conclude that a 
manipulation of the efflux determining AA ratio as achieved by ATD and APTD exerts 
opposing effects in the context of bimodal divided attention than solely referring to DA and 5-
HT availability. Due to the complex interplay of the various human metabolic pathways, 
additional effects of monoamine depletion cannot not be ruled out  (Crockett et al., 2012; Zepf 
et al., 2013). For instance, the kynurenine pathways are affected by ATD (Kennedy et al. 
2015). Several kynurenine metabolites can interact directly with central neural transmission 
(Schwarcz and Stone 2017), or indirectly e.g. by attenuating synthesis of tetrahydrobiopterin 
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(Haruki et al. 2016), which can serve as a crucial co-factor for the biosynthesis of the 5-HT 
and DA (Sperner-Unterweger et al. 2014).  
 
With regards to the translational value of such depletion experiments in different species, 
there is clear evidence that the depletion protocols used in the present study diminish 5-
HT/DA turnover in different strains of mice (Biskup et al. 2012; Sanchez et al. 2014). The 
particular translational value of such experiments conducted in rodents as done by Biskup et 
al. (2012) is that research in rodents allows highly invasive measurements that cannot be done 
in humans. In this particular study (Biskup et al. 2012), it was demonstrated that the Moja-De 
depletion paradigm decreased brain 5-HT in different brain areas, whereas influx kinetics as 
calculated for humans (see for example Dingerkus et al., 2012) can only be seen as an indirect 
measure or mathematical model of describing changed TRP-related influx kinetics after 
depletion across the blood brain barrier. Therefore, depletion protocols that can be used across 
different species have a great translational value, and because the Moja-De protocol can only 
be used in young people this particular depletion approach holds future promise to help to 
further disentangle the complex relationship between changes in TRP supply and influx, brain 
5-HT synthesis and symptoms observed in patients with psychiatric disorders from a 
developmental viewpoint. With many psychiatric disorders emerging in childhood and 
adolescents, such investigations can help to understand the roles of tryptophan and 5-HT in 
psychiatric disorders in young people  
 
A few limitations of the current study should be noted. These include the small sample size 
and the parallel design that could have lowered the statistical power. As calculated with 
G*power® a group size of at least 22 subjects would be necessary to reach a statistical power 
(1-β) of 0.8. No gender-related analysis was carried because of the preliminary and 
explorative nature of this study, in particular because a control for the menstrual phase would 
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have been valuable and this has been done in some previous studies (see Helmbold et al. 
2016), but much ATD-related research has been done in males and the impact of the 
menstrual phase on ATD-research has often been neglected (Mendelsohn et al. 2009). 
Serotonergic neurotransmission shows significant gender differences and is influenced by sex 
hormones which alternate throughout the menstrual cycle (Lasiuk and Hegadoren 2007).  
Notably, plasma levels of TRP show also cyclic changes coinciding with gonatropine levels 
during the menstrual cycle (Carretti et al. 2005). 
 
A separate execution of both tasks forming the dual task paradigm could also be considered in 
further studies. Additionally, this study was not able to assess whether the effect in the 
auditory condition would be present irrespective of the concomitant visual task. However, it 
seems likely that the current observations relating to the auditory condition would still stand, 
given the important role of 5-HT in the auditory system. Beside some limitations, this study 
sheds first light on a possible opponent modulation of a core attentional process via 5-HT and 
DA. However, further research is necessary to disentangle the interactions of 5-HT and DA in 
the context of divided attention. 
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Tab. 1 
 
 
 
 
 
 
 
 
 
Legend to Tab. 1: Characteristics of the study sample (data are presented as mean values (M) +/- standard deviation (SD). 
 
 
 
 
 
 
 
 
 
 
  
 n Weight (kg ±SD) Age (years ±SD) Gender f|m 
BAL 16 75,9 ±17,7 26,4 ±5,9 7|9 
ATD 16 71,2 ±13,5 24,4 ±4,2 8|8 
APTD 17 70,4 ±11,7 23,6 ± 3,1 8|9 
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Tab.2  
   T0 T6h 
   Mean SD Mean SD 
Phenylalanine         
 [µmol/L] BAL 63,87 25,10 203,17 110,71 
  ATD 59,16 10,46 187,14 78,74 
  PTD 56,34 12,76 37,27* 11,89 
Tryptophan          
 [µmol/L] BAL 68,39 12,34 176,40 46,20 
  ATD 64,04 11,97 41,50*  16,89 
  APTD 67,84 10,01 204,42 68,39 
Tyrosine          
 [µmol/L] BAL 57,89 16,63 72,36 23,40 
  ATD 56,22 10,08 78,68 22,71 
  APTD 56,53 12,77 20,76* 8,21 
BCCAs          
 [µmol/L] BAL 413,61 89,70 670,58 134,06 
  ATD 397,30 104,93 719,8 175,71 
  APTD 384,06 64,09 740,38 116,54 
   
        
Phenylalanine/∑LNAA         
  BAL 0,12 0,03 0,23 0,13 
  ATD 0,12 0,02 0,23 0,11 
  APTD 0,11 0,02 0,04* 0,01 
Tryptophan/∑LNAA         
  BAL 0,13 0,03 0,19 0,04 
  ATD 0,13 0,03 0,05* 0,02 
  APTD 0,14 0,02 0,26 0,08 
Tyrosine/∑LNAA         
  BAL 0,11 0,02 0,07 0,03 
  ATD 0,11 0,02 0,08 0,02 
  APTD 0,11 0,02 0,02* 0,01 
 
Legend to Tab. 2: The respective mean concentration ± standard deviation (SD) of all assessed AAs as well as the calculated 
AA ratios at each time point for each treatment group. (* = p < .001) 
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Tab. 3      
      
 
Mean ASTS score  ± SD at 
T0 
Mean ASTS score  ± SD at 
T4h  
"negative"      
BAL 44,31 ±9,87 43,63 ±10,29 n.s. 
APTD 41,41 ±5,59 42,82 ±4,72 n.s. 
ATD 41,44 ±6,43 42,00 ±9,24 n.s.      
 
"tired"      
BAL 10,25 ±4,81 8,81 ±5,09 n.s. 
APTD 8,82 ±2,67 8,29 ±3,67 n.s. 
ATD 8,94 ±3,4 8,06 ±4,15 n.s. 
  
 
Legend to Tab. 3: Data are presented as the mean ASTS scores ± standard deviation (SD). (n.s.: non-significant)  
 
Tab. 4 
  BAL  APTD  ATD   
  Mean SD Mean SD Mean SD  
Correct 
responses 
(number) 
 
12,88 3,48 13,00 2,67 13,25 4,53 
n.s. 
Reaction time 
(ms) 
 
564,69 114,98 604,82 128,93 600,50 162,00 
n.s. 
Omission 
errors 
(number) 
 
2,13 3,48 2,00 2,67 1,75 1,53 
n.s. 
   
  
 
 
Legend to Tab. 3: Results of the working memory task presented as the respective means ± standard deviation 
(SD). (n.s.: non-significant)  
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FIGURES 
 
Fig.1  
 
Legend to Fig. 1: The respective AA ratios at each time point for each treatment group 
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Fig. 2 
 
Legend to Fig. 2: Given are the mean reaction times to auditory stimuli for each condition. Error bars depict SEM. * p <0.05  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
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Fig. 3 
 
 
Legend to Fig. 3: Given are the mean reaction times to visual stimuli for each challenge condition. Error bars depict SEM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
